Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd VYYRF


Primary Symbol: V.VM

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Post by biggdoggon Mar 14, 2024 1:57pm
194 Views
Post# 35933185

Burn Baby Burn

Burn Baby Burn
This comment is what I am most interested in after reviewing the news.  The preparation of a carbon production Revenue Sharing Agreement is underway to exploit carbon captured and leverage the cash flow generated by carbon production technology at Voyageur's future pharmaceutical manufacturing facility. Voyageur is evaluating several existing pharmaceutical facilities, to enable the vertical integration of its pharmaceutical projects and align with its vision of integrating sustainability into pharmaceutical production
They are looking at pharmaceutical plants to buy? They must have financing to do this? Carbon revenue sharing? This means an entirely new revenue stream from a hydrocarbon generator energy. If I where in Vegas I would be betting on a large carbon farm being attached to the Voy project. According the GPTchat, 2.68 kg of CO2 from 1 litre of diesel. 0.2729 kg of carbon in 1 kg of CO2. 1 L diesel x .2729=0.73kg/L carbon. If they are burning 400L/hr, they are creating 292.5kg/hr carbon x 24hr =7 tonnes a day x 365=2,555 tonnes a year. This is going to get really damn good folks; I think this is going to blow the markets socks off when it becomes a reality. Fullerene is very valuable, currently $200/gram = $200,000,000 a tonne. If you just use hypotetically $100K/tonne they will be producing $255.5M a year of this new carbon material. If Voy gets just 10% of this revenue, the stock is going to Mars. This is based on 100% efficiency, which will never be the case.
 
<< Previous
Bullboard Posts
Next >>